Equity Overview
Price & Market Data
Price: $0.938
Daily Change: $0.00 / 0.00%
Daily Range: $0.938 - $0.938
Market Cap: $23,721,618
Daily Volume: 567
Performance Metrics
1 Week: -5.26%
1 Month: -11.56%
3 Months: -17.04%
6 Months: 15.74%
1 Year: 125.0%
YTD: -14.77%
Company Details
Employees: 8
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.